Myriad Genetics (MYGN) Current Leases: 2019-2025
Historic Current Leases for Myriad Genetics (MYGN) over the last 6 years, with Sep 2025 value amounting to $7.9 million.
- Myriad Genetics' Current Leases fell 41.48% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year decrease of 41.48%. This contributed to the annual value of $12.8 million for FY2024, which is 20.99% down from last year.
- According to the latest figures from Q3 2025, Myriad Genetics' Current Leases is $7.9 million, which was down 12.22% from $9.0 million recorded in Q2 2025.
- Myriad Genetics' Current Leases' 5-year high stood at $17.8 million during Q3 2023, with a 5-year trough of $7.9 million in Q3 2025.
- For the 3-year period, Myriad Genetics' Current Leases averaged around $13.4 million, with its median value being $13.5 million (2024).
- In the last 5 years, Myriad Genetics' Current Leases rose by 27.82% in 2023 and then tumbled by 41.48% in 2025.
- Myriad Genetics' Current Leases (Quarterly) stood at $13.0 million in 2021, then increased by 8.46% to $14.1 million in 2022, then grew by 14.89% to $16.2 million in 2023, then declined by 20.99% to $12.8 million in 2024, then tumbled by 41.48% to $7.9 million in 2025.
- Its Current Leases was $7.9 million in Q3 2025, compared to $9.0 million in Q2 2025 and $10.9 million in Q1 2025.